Medical Equipment Companies By Book Value Per Share Ratio

Book Value Per Share
Book Value Per ShareEfficiencyMarket RiskExp Return
1VTAK Catheter Precision
30.16
(0.05)
 5.26 
(0.26)
2MMSI Merit Medical Systems
22.71
(0.01)
 1.41 
(0.02)
3NVST Envista Holdings Corp
17.04
(0.04)
 2.33 
(0.10)
4EW Edwards Lifesciences Corp
16.18
 0.02 
 1.83 
 0.03 
5OFIX Orthofix Medical
13.07
(0.14)
 1.44 
(0.20)
6NDRA ENDRA Life Sciences
12.35
(0.04)
 5.34 
(0.20)
7NURO NeuroMetrix
7.86
 0.03 
 1.80 
 0.06 
8NARI Inari Medical
7.44
 0.17 
 5.32 
 0.91 
9NVRO Nevro Corp
7.31
 0.10 
 5.07 
 0.49 
10MHUA Meihua International Medical
5.73
(0.05)
 7.58 
(0.34)
11DXCM DexCom Inc
5.38
 0.13 
 2.01 
 0.26 
12ELMD Electromed
5.1
(0.04)
 3.56 
(0.13)
13NVCR Novocure
3.34
 0.05 
 7.19 
 0.36 
14NYXH Nyxoah
3.05
 0.11 
 3.09 
 0.35 
15NNOX Nano X Imaging
2.8
 0.03 
 6.82 
 0.20 
16WRBY Warby Parker
2.8
 0.05 
 2.82 
 0.13 
17NVNO enVVeno Medical Corp
2.7
 0.07 
 4.06 
 0.29 
18MOVE Movano Inc
2.54
(0.04)
 4.62 
(0.18)
19DRIO DarioHealth Corp
1.87
 0.04 
 13.28 
 0.52 
20NUWE Nuwellis
1.7
 0.00 
 5.11 
 0.01 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation. The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.